MELD 3.0 Score for Predicting Survival in Patients with Cirrhosis After Transjugular Intrahepatic Portosystemic Shunt Creation

被引:7
作者
Song, Jinlei [1 ,2 ]
Wang, Xiaoze [1 ]
Yan, Yuling [1 ]
Xiang, Tong [1 ]
Luo, Xuefeng [1 ]
机构
[1] Sichuan Univ, Sichuan Univ Univ Oxford Huaxi Joint Ctr Gastroint, West China Hosp, Dept Gastroenterol & Hepatol, 37 Guoxue Lane, Chengdu 610041, Sichuan, Peoples R China
[2] Third Hosp Mianyang, Dept Gastroenterol, 190 Jiannan Rd, Mianyang 612000, Sichuan, Peoples R China
关键词
Transjugular intrahepatic portosystemic shunt (TIPS); Liver cirrhosis; Portal hypertension; MELD; 3; 0; Survival; LIVER-DISEASE SCORE; FREIBURG INDEX; MODEL; MORTALITY; TIPS;
D O I
10.1007/s10620-023-07834-3
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and aimsThe selection of appropriate candidates for transjugular intrahepatic portosystemic shunt (TIPS) is important and challenging. To validate the Model for End-Stage Liver Disease (MELD) 3.0 in predicting mortality in patients with cirrhosis after TIPS creation.MethodsA total of 855 consecutive patients with cirrhosis from December 2011 to October 2019 who underwent TIPS placement were retrospectively reviewed. The prognostic value of the MELD 3.0, MELD, MELD-Na, Child-Pugh and FIPS score was assessed using Harrell's C concordance index (c-index). The Hosmer-Lemeshow test was used to test the goodness of fit of all models and the calibration plot was drawn.ResultsThe c-index of the MELD 3.0 in predicting 3-month mortality was 0.727 (0.645-0.808), which were significantly superior to the MELD (0.663 [0.565-0.761]; P = 0.015), MELD-Na (0.672 [0.577-0.768]; P = 0.008) and FIPS (0.582 [0.477-0.687]; P = 0.015). The Child-Pugh score reached c-indices of 0.754 (0.673-0.835), 0.720 (0.649-0.792), 0.705 (0.643-0.766) and 0.665 (0.614-0.716) for 3-month, 6-month, 1-year, and 2-year mortality, respectively, which seems comparable to MELD 3.0. A MELD 3.0 of 14 could be used as a cut-off point for discriminating between high- and low-risk patients. The MELD 3.0 could stratify patients with Child-Pugh grade B (log-rank P < 0.001). The Child-Pugh score could stratify patients defined as low risk by MELD 3.0 (log-rank P < 0.001).ConclusionsThe MELD 3.0 was significantly superior to the MELD, MELD-Na and FIPS scores in predicting mortality in patients with cirrhosis after TIPS creation.
引用
收藏
页码:3185 / 3192
页数:8
相关论文
共 25 条
  • [1] Application of the model for end-stage liver disease score for transjugular intrahepatic portosystemic shunt in cirrhotic patients with refractory ascites and renal impairment
    Alessandria, C
    Gaia, S
    Marzano, A
    Venon, WD
    Fadda, M
    Rizzetto, M
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2004, 16 (06) : 607 - 612
  • [2] Reduced Access to Liver Transplantation in Women: Role of Height, MELD Exception Scores, and Renal Function Underestimation
    Allen, Alina M.
    Heimbach, Julie K.
    Larson, Joseph J.
    Mara, Kristin C.
    Kim, W. Ray
    Kamath, Patrick S.
    Therneau, Terry M.
    [J]. TRANSPLANTATION, 2018, 102 (10) : 1710 - 1716
  • [3] Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt
    Angermayr, B
    Cejna, M
    Karnel, F
    Gschwantler, M
    Koenig, F
    Pidlich, J
    Mendel, H
    Pichler, L
    Wichlas, M
    Kreil, A
    Schmid, M
    Ferlitsch, A
    Lipinski, E
    Brunner, H
    Lammer, J
    Ferenci, P
    Gangl, A
    Peck-Radosavljevic, M
    [J]. GUT, 2003, 52 (06) : 879 - 885
  • [4] Procedural and shunt-related complications and mortality of the transjugular intrahepatic portosystemic shunt (TIPSS)
    Bettinger, D.
    Schultheiss, M.
    Boettler, T.
    Muljono, M.
    Thimme, R.
    Roessle, M.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (10) : 1051 - 1061
  • [5] Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival
    Bettinger, Dominik
    Sturm, Lukas
    Pfaff, Lena
    Hahn, Felix
    Kloeckner, Roman
    Volkwein, Lara
    Praktiknjo, Michael
    Lv, Yong
    Han, Guohong
    Huber, Jan Patrick
    Boettler, Tobias
    Reincke, Marlene
    Klinger, Christoph
    Caca, Karel
    Heinzow, Hauke
    Seifert, Leon Louis
    Weiss, Karl Heinz
    Rupp, Christian
    Piecha, Felix
    Kluwe, Johannes
    Zipprich, Alexander
    Luxenburger, Hendrik
    Neumann-Haefelin, Christoph
    Schmidt, Arthur
    Jansen, Christian
    Meyer, Carsten
    Uschner, Frank E.
    Brol, Maximilian J.
    Trebicka, Jonel
    Rossle, Martin
    Thimme, Robert
    Schultheiss, Michael
    [J]. JOURNAL OF HEPATOLOGY, 2021, 74 (06) : 1362 - 1372
  • [6] Evidence-based incorporation of serum sodium concentration into MELD
    Biggins, Scott W.
    Kim, W. Ray
    Terrault, Norah A.
    Saab, Sammy
    Balan, Vijay
    Schiano, Thomas
    Benson, Joanne
    Therneau, Terry
    Kremers, Walter
    Wiesner, Russell
    Kamath, Patrick
    Klintmalm, Goran
    [J]. GASTROENTEROLOGY, 2006, 130 (06) : 1652 - 1660
  • [7] Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
    D'Amico, G
    Garcia-Tsao, G
    Pagliaro, L
    [J]. JOURNAL OF HEPATOLOGY, 2006, 44 (01) : 217 - 231
  • [9] EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma (vol 69, pg 182, 2018)
    Galle, Peter R.
    Forner, Alejandro
    Llovet, Josep M.
    Mazzaferro, Vincenzo
    Piscaglia, Fabio
    Raoul, Jean-Luc
    Schirmacher, Peter
    Vilgrain, Valerie
    [J]. JOURNAL OF HEPATOLOGY, 2019, 70 (04) : 817 - 817
  • [10] A model to predict survival in patients with end-stage liver disease
    Kamath, PS
    Wiesner, RH
    Malinchoc, M
    Kremers, W
    Therneau, TM
    Kosberg, CL
    D'Amico, G
    Dickson, ER
    Kim, WR
    [J]. HEPATOLOGY, 2001, 33 (02) : 464 - 470